Literature DB >> 16771997

Editorial: 100 years of epidemic meningitis in West Africa - has anything changed?

Brian Greenwood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771997     DOI: 10.1111/j.1365-3156.2006.01639.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


× No keyword cloud information.
  32 in total

1.  Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Authors:  Ryan T Novak; Jean Ludovic Kambou; Fabien Vk Diomandé; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Clement Lingani; Stacey W Martin; Cynthia Hatcher; Leonard W Mayer; F Marc Laforce; Fenella Avokey; Mamoudou H Djingarey; Nancy E Messonnier; Sylvestre R Tiendrébéogo; Thomas A Clark
Journal:  Lancet Infect Dis       Date:  2012-07-18       Impact factor: 25.071

2.  Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Authors:  Danny Altmann; Abraham Aseffa; Margaret Bash; Nicole Basta; Ray Borrow; Claire Broome; Dominique Caugant; Tom Clark; Jean-Marc Collard; Mamoudou Djingarey; David Goldblatt; Brian Greenwood; Ulla Griffiths; Rana Hajjeh; Musa Hassan-King; Stephane Hugonnet; Ann Marie Kimball; Marc LaForce; Calman MacLennan; Martin C J Maiden; Olivier Manigart; Leonard Mayer; Nancy Messonnier; Jennifer Moisi; Katie Moore; Daugla Doumagoum Moto; Judith Mueller; Maria Nascimento; Stephen Obaro; Rasmata Ouedraogo; Anne-Laure Page; Willima Perea; Gerd Pluschke; Mari-Pierre Preziosi; Samba Sow; David Stephens; James Stuart; Madeleiene Thomson; Sylvestre Tiendrebeogo; Jean-Francois Trape; Guy Vernet
Journal:  Vaccine       Date:  2012-12-27       Impact factor: 3.641

Review 3.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

Review 4.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

5.  Long-term sequelae of childhood bacterial meningitis.

Authors:  Lee D Hudson; Russell M Viner; Deborah Christie
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

6.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  Changing epidemiology of bacterial meningitis.

Authors:  Mark Alain Dery; Rodrigo Hasbun
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725

8.  Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience.

Authors:  Jacqueline M Miller; Narcisa Mesaros; Marie Van Der Wielen; Yaela Baine
Journal:  Adv Prev Med       Date:  2011-07-18

9.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

10.  Aetiological agents of cerebrospinal meningitis: a retrospective study from a teaching hospital in Ghana.

Authors:  Michael Owusu; Samuel Blay Nguah; Yaw Agyekum Boaitey; Ernest Badu-Boateng; Abdul-Raman Abubakr; Robert Awuley Lartey; Yaw Adu-Sarkodie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-10-04       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.